Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening

Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening

Abstract Background According to international guidelines, HPV DNA tests represent a valid alternative to Pap Test for primary cervical cancer screening, provided that they guarantee balanced clinical sensitivity and specificity for cervical intraepithelial neoplasia grade 2 or more severe lesions....

Full description

Bibliographic Details
Main Authors: Michela Iacobellis, Cecilia Violante, Gabriella Notarachille, Angela Simone, Rosa Scarfì, Giuseppe Giuffrè
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Virology Journal
Subjects:
HPV
DNA testing
Primary cervical cancer screening
International guidelines
Online Access:http://link.springer.com/article/10.1186/s12985-018-0965-z

Internet

http://link.springer.com/article/10.1186/s12985-018-0965-z

Similar Items